New ED Drug Offers Hope For Men (NAPSA)—Akhtar Qureshi is an active man who hasbeen happily married for many years. He has always enjoyed spending time with his wife, which is why heinitially felt self-conscious before he learned that he is one of the 30 million men with erectile dysfunction (ED) in the United States. A decline in erectile function is a common health condition among men that is largely untreated. It is estimated that some degree of ED affects more than onehalf of all men over the age of 40. Despite the high prevalence of sexual problems, nine out of 10 men in the United States have not yet sought treatment from a physician. Qureshi first noticed a change with his erectile function nearly a decade ago, but like many other men, waited several years before approaching his doctor about it. He felt somewhat reluctant to discuss his symptoms, but after talking with some close friends, he made the decision to speak with his doctor. “Most men who notice a decrease in their erectile function wait several years before seeking treatment, hoping the issue will go away on its own,” said Myron Murdock, M.D., Levitra investigator and nationally-recognized expert in the field of male sexual dysfunction. “The condition not only has physical consequences for men, but could also emotionally impact their relationships. I ED Increases With Age 45 50 55 (Ot Mp @ encourage these men to raise the topic with their partners and to seek treatment.” “Given my positive experience in a clinical trial for Levitra, I am pleased it is now available,” Qureshi said. “Over the past few years, I’ve noticed a change in my erectile function—the quality of the erection wasn’t the same. In the clinical trial, Levitra worked consistently for me. I was able to count on my sexual response so I could perform the way that I knew T could.” Levitra is newly approved by the U.S. Food and Drug Administration (FDA) for the treatment of ED. It is the first oral prescription medication for ED to be approved by the FDAin five years. Levitra has demonstrated a rapid response, allowing a mantoinitiate or respond to sexual stimulation whenthetimeis right. “In clinical trials, Levitra helped men get and keep an erection sufficient for satisfactory sexual performance,” said Dr. Murdock. Levitra can be used to treat men who have an occasional or mild erectile problem as well as those with more frequent or severe difficulties. In clinical trials, Levitra worked in men of various ages and race and in those with co-existing medical conditions, such as diabetes, and in men who have had their prostate removed. Levitra is a prescription oral medication for the treatment of ED available only from doctors and should always be used in accordance with its approved labeling. Levitra may be used up to once a day to treat ED. Men taking nitrate drugs, often used to control chest pain (also known as angina), should not take Levitra. Men who use alpha blockers, sometimes prescribed for high blood pressure or prostate symptoms, also should not take Levitra. Such combinations could cause blood pressure to drop to an unsafe level. The most commonly reported side effects are headache, flushing and stuffy or runny nose. Men who experience an erection for more than four hours should seek immediate medical attention. To date, Levitra has been approved in more than 50 countries around the world. To learn more about Levitra, or to view the full prescribing information, please visit www.Levitra.com.
